CAPR News

Latest breaking news and updates for CAPR stock.

Track all markets on TradingView

Capricor Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPR

NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit. CL...

Will this litigation affect Capricor's ability to secure financing, continue R&D projects, or meet upcoming regulatory milestones? What has been the historical market reaction to similar class action lawsuits for biotech firms, and how might CAPR's stock volatility be affected? How likely is a settlement or judgment before the September 15, 2025 lead plaintiff deadline, and what are the potential financial impacts?
Lawsuits
about 14 hours ago
Read more prnewswire

Capricor Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Novel Exosome-Based Vaccine

SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today a...

Are there any contingent milestones, regulatory pathways, or additional funding requirements tied to the NIH Project NextGen partnership that could impact future cash flow or dilution risk? What is the competitive landscape for exosome‑based vaccines, and does Capricor have a differentiated platform versus peers like Moderna, BioNTech, and other exosome players? How will the Phase 1 data and timeline for StealthXℱ affect CAPR's near‑term valuation and trading volume?
Clinical trials
1 day ago
Read more globenewswire

Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR

LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ: CAPR ) for violat...

Are there comparable biotech companies that have faced similar securities lawsuits, and what were the market outcomes for those firms? How might this litigation impact CAPR's short‑term stock price volatility and liquidity, especially around upcoming corporate events or earnings releases? What is the expected timeline and potential financial liability of the securities class action lawsuit for Capricor?
Legal
1 day ago
Read more prnewswire

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, Aug. 18, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ("Capr...

What is the expected timeline for the case resolution and could it trigger further regulatory scrutiny or insider actions? How might the lawsuit affect the short‑term trading dynamics and liquidity of CAPR stock? What potential financial impact could the securities fraud lawsuit have on Capricor Therapeutics' valuation?
Lawsuits
2 days ago
Read more prnewswire

Capricor Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CAPR

NEW YORK, Aug. 15, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit. CL...

What is the potential effect of this lawsuit on short‑term trading volumes and volatility for CAPR stock? Could the legal proceedings affect Capricor's ongoing clinical trials or product development timelines? What disclosures have Capricor made regarding the lawsuit in its recent SEC filings, and do they reveal any material risks?
Lawsuits
5 days ago
Read more prnewswire

Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPR

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their Options If you purchased or acqu...

What steps can investors take now to mitigate risk exposure to CAPR pending the class‑action deadline? Are there any insider‑trading red‑flags or unusual activity in CAPR's stock that could be related to the pending litigation? How might the outcome of the class action influence analyst coverage, target‑price revisions, and institutional sentiment toward CAPR?
Legal
5 days ago
Read more prnewswire

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Capricor Therapeutics, Inc.(CAPR) Shareholders

NEW YORK, Aug. 14, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). Shareholders who purchased shares of CAPR durin...

How might investor sentiment and short interest shift in response to this negative news? What are the potential effects on CAPR's upcoming clinical trial timelines or partnerships if the lawsuit gains traction? Could the litigation trigger any covenant breaches or affect existing financing arrangements for CAPR?
Lawsuits
6 days ago
Read more prnewswire

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 13, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 202...

What impact could a negative outcome have on CAPR's pipeline projects, partnerships, or collaborations? How is the market currently pricing in litigation risk for CAPR, and does the current stock price reflect an over‑ or underestimation of that risk? Are there any insider trading restrictions or lock‑up periods being imposed on executives or major shareholders as a result of the case?
Lawsuits
6 days ago
Read more prnewswire